Apyx Medical Corp
For the period ended Dec 31, 2025. Filed Mar 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in Clearwater, Florida on March 10, 2026.
| Apyx Medical Corporation | |
| By: | /s/ Charles D. Goodwin II |
| Charles D. Goodwin II | |
| President, Chief Executive Officer and Director | |
| (Principal Executive Officer) | |
| By: | /s/ Matthew Hill |
| Matthew Hill | |
| Chief Financial Officer, | |
| Treasurer and Secretary | |
| (Principal Financial Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| Directors: | ||
| /s/ STAVROS VIZIRGIANAKIS | Chairperson of the Board of Directors | March 10, 2026 |
| Stavros Vizirgianakis | ||
| /s/ CHARLES D. GOODWIN II | Chief Executive Officer and Director | March 10, 2026 |
| Charles D. Goodwin II | ||
| /s/ MATTHEW HILL | Chief Financial Officer, Treasurer and Secretary | March 10, 2026 |
| Matthew Hill | ||
| /s/ LAWRENCE J. WALDMAN | Director | March 10, 2026 |
| Lawrence J. Waldman | ||
| /s/ MINNIE BAYLOR-HENRY | Director | March 10, 2026 |
| Minnie Baylor-Henry | ||
| /s/ WENDY LEVINE | Director | March 10, 2026 |
| Wendy Levine | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.